These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35417737)

  • 21. Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Prospective National Cohort Study, England.
    Amin-Chowdhury Z; Aiano F; Mensah A; Sheppard CL; Litt D; Fry NK; Andrews N; Ramsay ME; Ladhani SN
    Clin Infect Dis; 2021 Mar; 72(5):e65-e75. PubMed ID: 33196783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Investigating the association between ethnicity and health outcomes in SARS-CoV-2 in a London secondary care population.
    Patel A; Abdulaal A; Ariyanayagam D; Killington K; Denny SJ; Mughal N; Hughes S; Goel N; Davies GW; Moore LSP; Charani E
    PLoS One; 2020; 15(10):e0240960. PubMed ID: 33112892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England.
    Elliott P; Eales O; Bodinier B; Tang D; Wang H; Jonnerby J; Haw D; Elliott J; Whitaker M; Walters CE; Atchison C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Ward H; Darzi A; Cooke GS; Chadeau-Hyam M; Donnelly CA
    Nat Commun; 2022 Aug; 13(1):4500. PubMed ID: 35922409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study.
    Ray STJ; Abdel-Mannan O; Sa M; Fuller C; Wood GK; Pysden K; Yoong M; McCullagh H; Scott D; McMahon M; Thomas N; Taylor M; Illingworth M; McCrea N; Davies V; Whitehouse W; Zuberi S; Guthrie K; Wassmer E; Shah N; Baker MR; Tiwary S; Tan HJ; Varma U; Ram D; Avula S; Enright N; Hassell J; Ross Russell AL; Kumar R; Mulholland RE; Pett S; Galea I; Thomas RH; Lim M; Hacohen Y; Solomon T; Griffiths MJ; Michael BD; Kneen R;
    Lancet Child Adolesc Health; 2021 Sep; 5(9):631-641. PubMed ID: 34273304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. National and regional prevalence of SARS-CoV-2 antibodies in primary and secondary school children in England: the School Infection Survey, a national open cohort study, November 2021SARS-CoV-2 antibody prevalence in school children.
    Powell AA; Ireland G; Leeson R; Lacey A; Ford B; Poh J; Ijaz S; Shute J; Cherepanov P; Tedder R; Bottomley C; Dawe F; Mangtani P; Jones P; Nguipdop-Djomo P; Ladhani SN;
    J Infect; 2023 Apr; 86(4):361-368. PubMed ID: 36803676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 infection and transmission in primary schools in England in June-December, 2020 (sKIDs): an active, prospective surveillance study.
    Ladhani SN; Baawuah F; Beckmann J; Okike IO; Ahmad S; Garstang J; Brent AJ; Brent B; Walker J; Andrews N; Ireland G; Aiano F; Amin-Chowdhury Z; Letley L; Flood J; Jones SEI; Borrow R; Linley E; Zambon M; Poh J; Saliba V; Amirthalingam G; Lopez Bernal J; Brown KE; Ramsay ME
    Lancet Child Adolesc Health; 2021 Jun; 5(6):417-427. PubMed ID: 33740430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Large increases in SARS-CoV-2 seropositivity in children in England: Effects of the delta wave and vaccination.
    Oeser C; Whitaker H; Linley E; Borrow R; Tonge S; Brown CS; Gower C; Warrener L; Brown KE; Ramsay M; Amirthalingam G
    J Infect; 2022 Mar; 84(3):418-467. PubMed ID: 34861351
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London.
    Alhashmi A; Patel J; Janapala RN; Belfaqeeh O; Pourmand A
    Clin Radiol; 2021 Jun; 76(6):467. PubMed ID: 33894991
    [No Abstract]   [Full Text] [Related]  

  • 30. Epidemiology of Confirmed COVID-19 Deaths in Adults, England, March-December 2020.
    Brown AE; Heinsbroek E; Kall MM; Allen H; Beebeejaun K; Blomquist P; Campos-Matos I; Campbell CNJ; Mohammed H; Sinka K; Lamagni T; Phin N; Dabrera G;
    Emerg Infect Dis; 2021 May; 27(5):1468-1471. PubMed ID: 33900176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: COVID-19: could CT provide the best population level biomarker? Incidental COVID-19 in major trauma patients suggests higher than predicted rates of infection in London. A reply.
    Adam EJ; Grubnic S; Jacob TM; Patel JH; Blanks R
    Clin Radiol; 2021 Jun; 76(6):468-469. PubMed ID: 33832702
    [No Abstract]   [Full Text] [Related]  

  • 32. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study.
    Stephenson T; Pinto Pereira SM; Shafran R; de Stavola BL; Rojas N; McOwat K; Simmons R; Zavala M; O'Mahoney L; Chalder T; Crawley E; Ford TJ; Harnden A; Heyman I; Swann O; Whittaker E; ; Ladhani SN
    Lancet Child Adolesc Health; 2022 Apr; 6(4):230-239. PubMed ID: 35143770
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Race and COVID-19 Outcomes Among 2.6 Million Children in England.
    Saatci D; Ranger TA; Garriga C; Clift AK; Zaccardi F; Tan PS; Patone M; Coupland C; Harnden A; Griffin SJ; Khunti K; Dambha-Miller H; Hippisley-Cox J
    JAMA Pediatr; 2021 Sep; 175(9):928-938. PubMed ID: 34152371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nebulised surfactant for the treatment of severe COVID-19 in adults (COV-Surf): A structured summary of a study protocol for a randomized controlled trial.
    Dushianthan A; Clark H; Madsen J; Mogg R; Matthews L; Berry L; de la Serna JB; Batchelor J; Brealey D; Hussell T; Porter J; Djukanovic R; Feelisch M; Postle A; Grocott MPW
    Trials; 2020 Dec; 21(1):1014. PubMed ID: 33302976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disproportionate impact of SARS-CoV-2 on ethnic minority and frontline healthcare workers: A cross-sectional seroprevalence survey at a North London hospital.
    Martyn EM; Whitaker H; Gil E; Ighomereho P; Lambe G; Conley R; Saldiray J; Ladhani SN; Mirfenderesky M
    J Infect; 2021 Jun; 82(6):276-316. PubMed ID: 33676961
    [No Abstract]   [Full Text] [Related]  

  • 36. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
    Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
    Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Voluntary risk mitigation behaviour can reduce impact of SARS-CoV-2: a real-time modelling study of the January 2022 Omicron wave in England.
    Brooks-Pollock E; Northstone K; Pellis L; Scarabel F; Thomas A; Nixon E; Matthews DA; Bowyer V; Garcia MP; Steves CJ; Timpson NJ; Danon L
    BMC Med; 2023 Jan; 21(1):25. PubMed ID: 36658548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence of the reduction of acute circulating communicable viruses during the SARS-CoV-2 pandemic in London.
    Bramley A; Crocker-Buque T; Breuer J; Mahungu TW
    J Infect; 2021 Oct; 83(4):496-522. PubMed ID: 34419558
    [No Abstract]   [Full Text] [Related]  

  • 39. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England.
    Vusirikala A; Whitaker H; Jones S; Tessier E; Borrow R; Linley E; Hoschler K; Baawuah F; Ahmad S; Andrews N; Ramsay M; Ladhani SN; Brown KE; Amirthalingam G
    J Infect; 2021 Jul; 83(1):104-111. PubMed ID: 33933527
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.